Stay updated with breaking news from 09769810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 1,650,000 shares, an increase of 5.8% from the July 15th total of 1,560,000 shares. Based on an average daily volume of 134,600 shares, […]
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report) had its target price dropped by Stifel Nicolaus from $7.00 to $6.00 in a research note issued on Tuesday, FlyOnTheWall reports. Stifel Nicolaus’ price objective suggests a potential upside of 358.05% from the company’s current price. BOLT has been the topic of several other reports. HC Wainwright reiterated […]
Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) and Unity Biotechnology (NASDAQ:UBX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Earnings & Valuation This table compares Bolt Biotherapeutics and […]
Russell Investments Group Ltd. decreased its stake in shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Rating) by 38.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 40,195 shares of the company’s stock after selling 24,800 shares during the period. Russell Investments Group Ltd. owned […]
SVB Leerink upgraded shares of Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) from a market perform rating to an outperform rating in a research note published on Friday morning, PriceTargets.com reports. A number of other research firms have also weighed in on BOLT. HC Wainwright reissued a buy rating and set a $8.00 price target on […]